Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation

Details for Australian Patent Application No. 2003290596 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Eldrup, Anne B.; Crooke, Stanley T.; Bhat, Balkrishen; Griffey, Richard; Baker, Brenda F.; Swayze, Eric E.; Manoharan, Muthiah

Agent Pizzeys

Pub. Number AU-B-2003290596

PCT Number PCT/US2003/0350

PCT Pub. Number WO2004/043979

Priority 60/423,760 05.11.02 US

Filing date 4 November 2003

Wipo publication date 3 June 2004

Acceptance publication date 12 May 2011

International Classifications

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 60/423,760 05.11.02 US

8 July 2004 Application Open to Public Inspection

  Published as AU-B-2003290596

30 June 2005 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Jun 2005

12 May 2011 Application Accepted

  Published as AU-B-2003290596

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003290597-MODIFIED OLIGONUCLEOTIDES FOR USE IN RNA INTERFERENCE

2003290595-FOLDING CABINET BED